Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Prolyl Hydroxylase Domain-Containing Protein 2 (PHD2) is a key oxygen-sensing enzyme that regulates the stability of hypoxia-inducible factor alpha (HIF-α) proteins. It catalyzes the proline hydroxylation of HIF-α, targeting it for degradation under normoxic conditions. PHD2 plays a crucial role in cellular adaptation to hypoxia by controlling the expression of genes involved in angiogenesis, erythropoiesis, and glycolysis. Dysregulation of PHD2 is implicated in various diseases, including cancer and immune disorders.
Inhibition of proline hydroxylation on HIF-α, leading to HIF-α stabilization and increased transcriptional activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prolyl Hydroxylase Domain-Containing Protein 2 (PHD2).